AGENOVIR CORPORATION
Biotech · Acquired
CRISPR-Cas nuclease therapeutic targeting EBV DNA genome in donor organs ex vivo prior to transplantation
- Grants
- $150K
- 1 award
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 40
- 1 granted · 39 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20152016
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · CRISPR-based anti-viral therapeutics to eliminate EBV-associated post-transplant lymphoproliferative disease | $149,972 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1652 | Eureka Therapeutics, Inc. | — | $86M |
| 1653 | ALPH TECHNOLOGIES LLC | — | — |
| 1654 | Doric Pharma | — | — |
| 1655 | AGENOVIR CORPORATION | — | — |
| 1656 | FOR-ROBIN, INC. | — | — |
| 1657 | OncoSpherix, Inc. | — | — |
| 1658 | PHAGE REFINERY, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Compositions And Methods To Treat Herpes Simplex Virus Infectionsapplication
- Compositions And Methods For Cell Targeted Hpv Treatmentapplication
- Compositions And Methods To Treat Herpes Simplex Virus Infectionsgranted
- Antiviral Treatment With Low Immunogenicityapplication
- Antiviral Nuclease Methodsapplication
- Oncoviral Treatment With Nuclease And Chemotherapeuticapplication
- Modified Antiviral Nucleaseapplication
- Transgenic Nuclease Systems And Methodsapplication
- Compositions And Methods For Latent Viral Transcription Regulationapplication
- Compositions And Methods For Treatment Of Latent Viral Infectionsapplication
- Antiviral Fusion Proteins And Genesapplication
- Delivery Methods And Compositionsapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.